Related Experiment Video

Updated: Jan 20, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

43.0K

Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance

Margherita Puppo1, Hanna Taipaleenmäki2, Eric Hesse2,3

  • 1Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.

British Journal of Pharmacology
|August 20, 2019
PubMed

Insights

Non-coding RNAs (ncRNAs) are key regulators in the development of bone metastases. Targeting these molecules offers new therapeutic strategies and potential biomarkers for advanced cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bone metastases are a common and severe complication in advanced cancer patients.
  • Current treatments for bone metastases are primarily palliative, highlighting the need for novel therapeutic approaches.
  • Understanding the molecular mechanisms driving skeletal lesion development is crucial for improving patient outcomes.

Purpose of the Study:

  • To review the emerging role of non-coding RNAs (ncRNAs) in the formation of bone metastases.
  • To explore the potential of ncRNAs as therapeutic targets for bone metastasis.
  • To discuss the utility of ncRNAs as biomarkers for bone metastases and their impact on treatment response.

Main Methods:

  • Literature review focusing on non-coding RNAs (ncRNAs) in bone metastasis.
  • Analysis of evidence implicating long ncRNAs, microRNAs, and circular RNAs in skeletal lesion development.
  • Synthesis of current knowledge on therapeutic targeting and biomarker potential of ncRNAs.

Main Results:

  • Non-coding RNAs (ncRNAs), including long ncRNAs, microRNAs, and circular RNAs, are identified as critical regulators of bone metastasis.
  • Evidence suggests ncRNAs play a master regulatory role in the transition from primary cancer to bone lesions.
  • ncRNAs present promising avenues for targeted therapies and diagnostic/prognostic applications.

Conclusions:

  • Non-coding RNAs (ncRNAs) are pivotal in the pathogenesis of bone metastases.
  • Targeting ncRNAs offers a promising strategy for developing more effective treatments for bone metastases.
  • ncRNAs hold significant potential as biomarkers to guide treatment decisions and improve patient management in advanced cancer.

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.2K
Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry08:24

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry

Published on: March 14, 2020

7.3K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.5K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Spongy Bone01:09

Spongy Bone

All bones comprise an outer layer of compact bone, and an interior made up of spongy bone tissue, also called cancellous or trabecular bone. In long bones, spongy bone tissue is mainly found in the interior of the epiphyses (broad ends of the bone).
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
7.6K
Compact Bone01:27

Compact Bone

Most bones contain compact and spongy osseous tissue, but their distribution and concentration vary based on the bone's overall function.
Compact bone, also called cortical bone, is the denser, stronger of the two types of bone tissue. It is found under the periosteum and in the diaphyses of long bones, where it provides support and protection. The microscopic structural unit of compact bone is called an osteon, or haversian system. Each osteon is composed of concentric rings of calcified...
16.1K